Boston Therapeutics, Inc. Business Finance Contracts & Agreements

81 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Nanomix Corporation Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2023
Securities Purchase Agreement between Nanomix Corporation and Purchasers dated October 21, 2022
Subscription Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Description of Securities Registered Under Section 12 of the Exchange Act – Nanomix Corporation
Stock Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Consent, Amendment and Waiver Agreement between Nanomix Corporation and HT Investments MA LLC (March 22, 2022)
Waiver Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Securities Purchase Agreement between NanoMix Corporation and Purchaser (March 2022)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Consent, Amendment and Waiver Agreement between Nanomix Corporation and HT Investments MA LLC (February 24, 2022)
Waiver Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Nanomix Corporation Securities Purchase Agreement with Investors (February 25, 2022)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Nanomix Corporation Senior Secured Convertible Note, Issued February 25, 2022
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Exchange Agreement between Boston Therapeutics, Inc. and Holder for Convertible Promissory Notes (June 2021)
Exchange Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Security and Pledge Agreement between Boston Therapeutics, Inc., Subsidiaries, and HT Investments MA LLC (Collateral Agent) dated June 25, 2021
Security Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Registration Rights Agreement between Boston Therapeutics, Inc. and Buyers (June 25, 2021)
Registration Rights Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Securities Purchase Agreement between Boston Therapeutics, Inc. and Investors (June 25, 2021)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Boston Therapeutics, Inc. Senior Secured Convertible Note dated June 25, 2021
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Nanomix, Inc. 10% Secured Promissory Note to Boston Therapeutics, Inc. (April 30, 2021)
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Secured Promissory Note between Boston Therapeutics, Inc. and Gold Blaze Limited (April 30, 2021)
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Exchange Agreement between Boston Therapeutics, Inc. and Holder for Securities-for-Shares Transaction
Exchange Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Boston Therapeutics, Inc. $100,000 Promissory Note Dated June 12, 2018
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
MA
2018
Contribution Agreement between Boston Therapeutics, Inc., CureDM Group Holdings, LLC, and CureDM Members (January 1, 2018)
Contribution Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2018
Common Stock Purchase Warrant Agreement between Boston Therapeutics, Inc. and Holder
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2017
Securities Purchase Agreement between Boston Therapeutics, Inc. and Purchasers (2017)
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Securities Purchase Agreement between Boston Therapeutics, Inc. and Purchaser
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Amendment to 10% Convertible Promissory Notes between Boston Therapeutics Inc. and CJY Holdings Limited
Note Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Boston Therapeutics, Inc. Securities Purchase Agreement with Purchasers
Purchase Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2016
Nanomix, Inc. Warrant to Purchase Common Stock (Assumed in Merger)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
CA
2022
Common Stock Purchase Warrant Agreement between Nanomix Corporation and GHS Investments, LLC (March 23, 2022)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2022
Nanomix Corporation Warrant to Purchase Common Stock, Dated February 25, 2022
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2022
Guaranty Agreement by Boston Therapeutics, Inc. Subsidiaries in Favor of HT Investments MA LLC (June 25, 2021)
Guaranty Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Boston Therapeutics, Inc. Warrant to Purchase Common Stock, Dated June 25, 2021
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Debt Settlement and Release Agreement between Boston Therapeutics, Inc. and Creditor
Release Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2021
Unwind Agreement between Boston Therapeutics, Inc., CureDM, Inc., and CureDM Group Holdings, LLC (August 6, 2019)
Release Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2019
Boston Therapeutics, Inc. Stock Purchase Warrant Agreement (April 2017)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2017
Boston Therapeutics, Inc. 6% Subordinated Convertible Debenture Due 2019
Debenture Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2017
Amendment to Executive Employment Agreement between Boston Therapeutics, Inc. and Carl W. Rausch
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2017
Boston Therapeutics, Inc. Stock Purchase Warrant Agreement (June 2016)
Warrant Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
DE
2016
Boston Therapeutics, Inc. 6% Senior Convertible Debenture Due 2018
Debenture Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
NY
2016
Amendment to Securities Purchase Agreement between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2016
Amendment to Securities Purchase Agreement Between Boston Therapeutics Inc. and CJY Holdings Limited
Modification Agreements
Boston Therapeutics, Inc.
Pharmaceuticals
2015